255 related articles for article (PubMed ID: 34070502)
21. Chemotherapeutic resistance of head and neck squamous cell carcinoma is mediated by EpCAM induction driven by IL-6/p62 associated Nrf2-antioxidant pathway activation.
Noman ASM; Parag RR; Rashid MI; Islam S; Rahman MZ; Chowdhury AA; Sultana A; Jerin C; Siddiqua A; Rahman L; Nayeem J; Akther S; Baidya S; Shil RK; Rahman M; Shirin A; Mahmud R; Hossain SMI; Sumi SA; Chowdhury A; Basher SB; Hasan A; Bithy S; Aklima J; Chowdhury N; Hasan MN; Banu T; Chowdhury S; Hossain MM; Yeger H; Farhat WA; Islam SS
Cell Death Dis; 2020 Aug; 11(8):663. PubMed ID: 32814771
[TBL] [Abstract][Full Text] [Related]
22. Up-regulated Wnt1-inducible signaling pathway protein 1 correlates with poor prognosis and drug resistance by reducing DNA repair in gastric cancer.
Zhang LH; Wang Y; Fan QQ; Liu YK; Li LH; Qi XW; Mao Y; Hua D
World J Gastroenterol; 2019 Oct; 25(38):5814-5825. PubMed ID: 31636474
[TBL] [Abstract][Full Text] [Related]
23. Flumethasone enhances the efficacy of chemotherapeutic drugs in lung cancer by inhibiting Nrf2 signaling pathway.
Zhou Y; Zhou Y; Wang K; Li T; Yang M; Wang R; Chen Y; Cao M; Hu R
Cancer Lett; 2020 Apr; 474():94-105. PubMed ID: 31954771
[TBL] [Abstract][Full Text] [Related]
24. An overview of chemical inhibitors of the Nrf2-ARE signaling pathway and their potential applications in cancer therapy.
Zhu J; Wang H; Chen F; Fu J; Xu Y; Hou Y; Kou HH; Zhai C; Nelson MB; Zhang Q; Andersen ME; Pi J
Free Radic Biol Med; 2016 Oct; 99():544-556. PubMed ID: 27634172
[TBL] [Abstract][Full Text] [Related]
25. TCF7L1 indicates prognosis and promotes proliferation through activation of Keap1/NRF2 in gastric cancer.
Zhang B; Wu J; Cai Y; Luo M; Wang B; Gu Y
Acta Biochim Biophys Sin (Shanghai); 2019 Apr; 51(4):375-385. PubMed ID: 30811526
[TBL] [Abstract][Full Text] [Related]
26. The Nrf2/HO-1 Axis in Cancer Cell Growth and Chemoresistance.
Furfaro AL; Traverso N; Domenicotti C; Piras S; Moretta L; Marinari UM; Pronzato MA; Nitti M
Oxid Med Cell Longev; 2016; 2016():1958174. PubMed ID: 26697129
[TBL] [Abstract][Full Text] [Related]
27. NRF2 addiction in cancer cells.
Kitamura H; Motohashi H
Cancer Sci; 2018 Apr; 109(4):900-911. PubMed ID: 29450944
[TBL] [Abstract][Full Text] [Related]
28. Nrf2: a potential therapeutic target for naturally occurring anticancer drugs?
Catanzaro E; Calcabrini C; Turrini E; Sestili P; Fimognari C
Expert Opin Ther Targets; 2017 Aug; 21(8):781-793. PubMed ID: 28675319
[TBL] [Abstract][Full Text] [Related]
29. Counteracting role of nuclear factor erythroid 2-related factor 2 pathway in Alzheimer's disease.
Sharma V; Kaur A; Singh TG
Biomed Pharmacother; 2020 Sep; 129():110373. PubMed ID: 32603894
[TBL] [Abstract][Full Text] [Related]
30. The role of Her2-Nrf2 axis in induction of oxaliplatin resistance in colon cancer cells.
Pirpour Tazehkand A; Akbarzadeh M; Velaie K; Sadeghi MR; Samadi N
Biomed Pharmacother; 2018 Jul; 103():755-766. PubMed ID: 29684854
[TBL] [Abstract][Full Text] [Related]
31. Role of Nrf2 and mitochondria in cancer stem cells; in carcinogenesis, tumor progression, and chemoresistance.
Payandeh Z; Pirpour Tazehkand A; Barati G; Pouremamali F; Kahroba H; Baradaran B; Samadi N
Biochimie; 2020 Dec; 179():32-45. PubMed ID: 32946993
[TBL] [Abstract][Full Text] [Related]
32. Enhanced B-Raf-mediated NRF2 gene transcription and HATs-mediated NRF2 protein acetylation contributes to ABCC1-mediated chemoresistance and glutathione-mediated survival in acquired topoisomerase II poison-resistant cancer cells.
Chen HH; Chang HH; Chang JY; Tang YC; Cheng YC; Lin LM; Cheng SY; Huang CH; Sun MW; Chen CT; Kuo CC
Free Radic Biol Med; 2017 Dec; 113():505-518. PubMed ID: 29080842
[TBL] [Abstract][Full Text] [Related]
33. The Nuclear Factor (Erythroid-derived 2)-like 2 and Proteasome Maturation Protein Axis Mediate Bortezomib Resistance in Multiple Myeloma.
Li B; Fu J; Chen P; Ge X; Li Y; Kuiatse I; Wang H; Wang H; Zhang X; Orlowski RZ
J Biol Chem; 2015 Dec; 290(50):29854-68. PubMed ID: 26483548
[TBL] [Abstract][Full Text] [Related]
34. Involvement of NRF2 in Breast Cancer and Possible Therapeutical Role of Polyphenols and Melatonin.
Tascioglu Aliyev A; Panieri E; Stepanić V; Gurer-Orhan H; Saso L
Molecules; 2021 Mar; 26(7):. PubMed ID: 33805996
[TBL] [Abstract][Full Text] [Related]
35. Gene-expression signature regulated by the KEAP1-NRF2-CUL3 axis is associated with a poor prognosis in head and neck squamous cell cancer.
Namani A; Matiur Rahaman M; Chen M; Tang X
BMC Cancer; 2018 Jan; 18(1):46. PubMed ID: 29306329
[TBL] [Abstract][Full Text] [Related]
36. DJ-1 is involved in the multidrug resistance of SGC7901 gastric cancer cells through PTEN/PI3K/Akt/Nrf2 pathway.
Qiu L; Ma Z; Li X; Deng Y; Duan G; Zhao LE; Xu X; Xiao L; Liu H; Zhu Z; Chen H
Acta Biochim Biophys Sin (Shanghai); 2020 Dec; 52(11):1202-1214. PubMed ID: 33079995
[TBL] [Abstract][Full Text] [Related]
37. The Nrf2 transcription factor contributes to resistance to cisplatin in bladder cancer.
Hayden A; Douglas J; Sommerlad M; Andrews L; Gould K; Hussain S; Thomas GJ; Packham G; Crabb SJ
Urol Oncol; 2014 Aug; 32(6):806-14. PubMed ID: 24837013
[TBL] [Abstract][Full Text] [Related]
38. Contradictory roles of Nrf2/Keap1 signaling pathway in cancer prevention/promotion and chemoresistance.
Jeddi F; Soozangar N; Sadeghi MR; Somi MH; Samadi N
DNA Repair (Amst); 2017 Jun; 54():13-21. PubMed ID: 28415030
[TBL] [Abstract][Full Text] [Related]
39. Nuclear factor erythroid 2-related factor 2 nuclear translocation induces myofibroblastic dedifferentiation in idiopathic pulmonary fibrosis.
Artaud-Macari E; Goven D; Brayer S; Hamimi A; Besnard V; Marchal-Somme J; Ali ZE; Crestani B; Kerdine-Römer S; Boutten A; Bonay M
Antioxid Redox Signal; 2013 Jan; 18(1):66-79. PubMed ID: 22703534
[TBL] [Abstract][Full Text] [Related]
40. [Role of Nrf2 in neurodegenerative diseases and recent progress of its activators].
Zhao CY; Wang XL; Peng Y
Yao Xue Xue Bao; 2015 Apr; 50(4):375-84. PubMed ID: 26223117
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
